Fulvestrant plus targeted agents versus fulvestrant alone for treatment of hormone-receptor positive advanced breast cancer progressed on previous endocrine therapy: a meta-analysis of randomized controlled trials Wen-Zhao LinQi-Ni XuXu-Yuan Li Review Article 21 March 2017 Pages: 345 - 352
Ductal carcinoma in situ and ductal carcinoma in situ with microinvasion: correlation of FDG uptake with histological and biological prognostic factors Ye Young SeoIe Ryung YooHyung Sun Sohn Original Article 16 June 2016 Pages: 353 - 361
Long-term prospective assessment of shoulder function after breast reconstruction involving a latissimus dorsi muscle flap transfer and postoperative radiotherapy Yoshihiro SowaToru MoriharaToshiaki Numajiri Original Article 05 July 2016 Pages: 362 - 368
Genetic variants of ESR1 and SGSM3 are associated with the susceptibility of breast cancer in the Chinese population Tan TanKai ZhangWenjun Chen Sun Original Article 18 July 2016 Pages: 369 - 374
Erratum to: Genetic variants of ESR1 and SGSM3 are associated with the susceptibility of breast cancer in the Chinese population Tan TanKai ZhangWenjun Chen Erratum 11 October 2016 Pages: 375 - 375
Verbal fluency in breast cancer patients treated with chemotherapy Paulina AndryszakMonika WiłkośćPaweł Izdebski Original Article Open access 19 July 2016 Pages: 376 - 383
The relationship between the expression of FOXA1 and GATA3 and the efficacy of neoadjuvant endocrine therapy Kimihiro TanakaEriko TokunagaYoshihiko Maehara Original Article 29 July 2016 Pages: 384 - 392
Expression of cell polarity protein scribble differently affects prognosis in primary tumor and lymph node metastasis of breast cancer patients Junta SakakibaraMasahiro SakakibaraMasaru Miyazaki Original Article 25 August 2016 Pages: 393 - 399
Hormone receptor status of contralateral breast cancers: analysis of data from the US SEER population-based registries Roman MezencevMarián Švajdler Jr. Original Article 08 August 2016 Pages: 400 - 410
Feasibility and potential limitations of abbreviated breast MRI: an observer study using an enriched cohort Youichi MachidaAkiko ShimauchiEisuke Fukuma Original Article 02 August 2016 Pages: 411 - 419
Genetic polymorphisms in APE1 Asp148Glu(rs3136820) as a modifier of the background levels of abasic sites in human leukocytes derived from breast cancer patients and controls Wei-Chung HsiehChe LinPo-Hsiung Lin Original Article 18 August 2016 Pages: 420 - 426
Trends in axillary treatment for breast cancer patients undergoing sentinel lymph node biopsy as determined by a questionnaire from the Japanese Breast Cancer Society Shigeru ImotoChikako YamauchiKimiyasu Yoneyama Original Article 23 August 2016 Pages: 427 - 432
Med19 promotes breast cancer cell proliferation by regulating CBFA2T3/HEB expression Xiufen ZhangYanling FanLihua Li Original Article 29 August 2016 Pages: 433 - 441
Detectability comparison of modes in dual-mode digital breast tomosynthesis Tokiko EndoTakako MoritaTakahisa Arai Original Article 01 September 2016 Pages: 442 - 450
Current trends and outcomes of breast reconstruction following nipple-sparing mastectomy: results from a national multicentric registry with 1006 cases over a 6-year period Donato CasellaClaudio CalabreseMarco Bernini Original Article 06 September 2016 Pages: 451 - 457
Breast reconstruction using free medial circumflex artery perforator flaps: intraoperative anatomic study and clinical results Mai ShibuyaToshihiko SatakeJiro Maegawa Original Article 13 September 2016 Pages: 458 - 464
Erratum to: Breast reconstruction using free medial circumflex femoral artery perforator flaps: intraoperative anatomic study and clinical results Mai ShibuyaToshihiko SatakeJiro Maegawa Erratum 28 November 2016 Pages: 465 - 465
Mammographic extent of microcalcifications and oestrogen receptor expression affect preoperative breast carcinoma in situ size estimation Maria Vernet-TomasSergi MojalDolors Sabadell Original Article 17 September 2016 Pages: 466 - 472
Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer Akiko OgiyaKieko YamazakiCollaborative Study Group of Scientific Research of the Japanese Breast Cancer Society Original Article 15 September 2016 Pages: 473 - 482
A study of tumor heterogeneity in a case with breast cancer Haruka NakadaHiroshi NakagomiMasao Omata Case Report 29 September 2016 Pages: 483 - 489
Does longer disease-free interval affect the complete remission in metastatic breast cancer? Kadri Altundag Letter to the Editor 16 February 2017 Pages: 490 - 490
Disease-free interval in metastatic breast cancer patients undergoing complete remission: implications of cross-sectional study design and biologic considerations about disease history Giulia GalliAnna TessariSerena Di Cosimo Author’s reply 06 March 2017 Pages: 491 - 492